Study to Evaluate Botulinum Neurotoxin Serotype E (EB-001) in Reducing Musculoskeletal Pain in Abdominoplasty

计划入组 23 人 · 首次发布于 2018 年 2 月 12 日

Oral Zinc Supplementation to Enhance Botulinum Neurotoxin Response

计划入组 54 人 · 首次发布于 2021 年 10 月 27 日

Efficacy and Safety Study of Botulinum Neurotoxin A With Rehabilitation Versus Botulinum Neurotoxin A Alone in Treatment of Post-stroke Spasticity

计划入组 31 人 · 首次发布于 2009 年 7 月 24 日

Equine Botulinum Neurotoxin E Immune FAB2(BAT)

Equine Botulinum Neurotoxin B Immune FAB2(BAT)

Equine Botulinum Neurotoxin F Immune FAB2(BAT)

Dong-E-E-Jiao Co.,Ltd.

China

BIOLOGICAL E. LIMITED

India

Biological E Limited.

United States

FDA Issues Complete Response Letter for AbbVie's Novel Botulinum Toxin TrenibotE Over Manufacturing Concerns

FDA Complete Response Letters: How CRLs Reshape Biotech Valuations and Drug Development Timelines

AbbVie Seeks FDA Approval for Novel Serotype E Botulinum Neurotoxin for Glabellar Lines